Het metabool syndroom bij kinderen en jongeren

Het belang van monitoring bij een behandeling met atypische antipsychotica

M. Deleu*, D. Neves Ramos, A. Janssens, D. Deboutte

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Background: A substantial increase in the use of second-generation or atypical antipsychotics in young persons has occurred. This use has been associated in children and adolescents with metabolic disturbances. Objective: This article reviews the literature concerning the metabolic side effects of second-generation antipsychotics based on the consensus definition of the metabolic syndrome in youngsters. Method: A literature search on the definition of the metabolic syndrome in youngsters and the metabolic side effects of second-generation antipsychotics in children and adolescents was performed. Results: Little is known about the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Only the risk of a weight gain is proven to be significant. Based on the definition of the Metabolic Syndrome in children and adolescents, suggested bij the International Diabetes Federation, we discuss the different components of this consensus and assess its applicability on Belgian youngsters. We suggest a safety protocol in clinical practice for monitoring metabolic side effects of second-generation antipsychotics. Conclusions: No consensus does exist concerning the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Until further research is performed we advise carefulness and follow-up while prescribing this medication to youngsters.

OriginalsprogNederlandsk
TidsskriftTijdschrift voor Geneeskunde
Vol/bind67
Udgave nummer6
Sider (fra-til)288-298
ISSN0371-683X
DOI
StatusUdgivet - 20. apr. 2011
Udgivet eksterntJa

Fingeraftryk

Cohort Effect
Weight Gain
Safety
Research

Citer dette

@article{17c56c2a68584b538ed6eb59180e7642,
title = "Het metabool syndroom bij kinderen en jongeren: Het belang van monitoring bij een behandeling met atypische antipsychotica",
abstract = "Background: A substantial increase in the use of second-generation or atypical antipsychotics in young persons has occurred. This use has been associated in children and adolescents with metabolic disturbances. Objective: This article reviews the literature concerning the metabolic side effects of second-generation antipsychotics based on the consensus definition of the metabolic syndrome in youngsters. Method: A literature search on the definition of the metabolic syndrome in youngsters and the metabolic side effects of second-generation antipsychotics in children and adolescents was performed. Results: Little is known about the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Only the risk of a weight gain is proven to be significant. Based on the definition of the Metabolic Syndrome in children and adolescents, suggested bij the International Diabetes Federation, we discuss the different components of this consensus and assess its applicability on Belgian youngsters. We suggest a safety protocol in clinical practice for monitoring metabolic side effects of second-generation antipsychotics. Conclusions: No consensus does exist concerning the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Until further research is performed we advise carefulness and follow-up while prescribing this medication to youngsters.",
author = "M. Deleu and {Neves Ramos}, D. and A. Janssens and D. Deboutte",
year = "2011",
month = "4",
day = "20",
doi = "10.2143/TVG.67.06.2000933",
language = "Nederlandsk",
volume = "67",
pages = "288--298",
journal = "Tijdschrift voor Geneeskunde",
issn = "0371-683X",
publisher = "Tijdschrift voor Geneeskunde A.S.B.L.",
number = "6",

}

Het metabool syndroom bij kinderen en jongeren : Het belang van monitoring bij een behandeling met atypische antipsychotica. / Deleu, M.; Neves Ramos, D.; Janssens, A.; Deboutte, D.

I: Tijdschrift voor Geneeskunde, Bind 67, Nr. 6, 20.04.2011, s. 288-298.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Het metabool syndroom bij kinderen en jongeren

T2 - Het belang van monitoring bij een behandeling met atypische antipsychotica

AU - Deleu, M.

AU - Neves Ramos, D.

AU - Janssens, A.

AU - Deboutte, D.

PY - 2011/4/20

Y1 - 2011/4/20

N2 - Background: A substantial increase in the use of second-generation or atypical antipsychotics in young persons has occurred. This use has been associated in children and adolescents with metabolic disturbances. Objective: This article reviews the literature concerning the metabolic side effects of second-generation antipsychotics based on the consensus definition of the metabolic syndrome in youngsters. Method: A literature search on the definition of the metabolic syndrome in youngsters and the metabolic side effects of second-generation antipsychotics in children and adolescents was performed. Results: Little is known about the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Only the risk of a weight gain is proven to be significant. Based on the definition of the Metabolic Syndrome in children and adolescents, suggested bij the International Diabetes Federation, we discuss the different components of this consensus and assess its applicability on Belgian youngsters. We suggest a safety protocol in clinical practice for monitoring metabolic side effects of second-generation antipsychotics. Conclusions: No consensus does exist concerning the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Until further research is performed we advise carefulness and follow-up while prescribing this medication to youngsters.

AB - Background: A substantial increase in the use of second-generation or atypical antipsychotics in young persons has occurred. This use has been associated in children and adolescents with metabolic disturbances. Objective: This article reviews the literature concerning the metabolic side effects of second-generation antipsychotics based on the consensus definition of the metabolic syndrome in youngsters. Method: A literature search on the definition of the metabolic syndrome in youngsters and the metabolic side effects of second-generation antipsychotics in children and adolescents was performed. Results: Little is known about the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Only the risk of a weight gain is proven to be significant. Based on the definition of the Metabolic Syndrome in children and adolescents, suggested bij the International Diabetes Federation, we discuss the different components of this consensus and assess its applicability on Belgian youngsters. We suggest a safety protocol in clinical practice for monitoring metabolic side effects of second-generation antipsychotics. Conclusions: No consensus does exist concerning the metabolic long term risks due to the use of atypical antipsychotics in children and adolescents. Until further research is performed we advise carefulness and follow-up while prescribing this medication to youngsters.

U2 - 10.2143/TVG.67.06.2000933

DO - 10.2143/TVG.67.06.2000933

M3 - Tidsskriftartikel

VL - 67

SP - 288

EP - 298

JO - Tijdschrift voor Geneeskunde

JF - Tijdschrift voor Geneeskunde

SN - 0371-683X

IS - 6

ER -